The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Pázmándi, K. L.,
Szöllősi, A. G.,
Fekete, T.:
The "root" causes behind the anti-inflammatory actions of ginger compounds in immune cells.
Front. Immunol. 15, 1-17, (article identifier: 1400956), 2024.
Bencze, D.,
Fekete, T.,
Pázmándi, K. L.:
Correlation between Type I Interferon Associated Factors and COVID-19 Severity.
Int. J. Mol. Sci. 23 (18), 1-26, (article identifier: 10968), 2022.
Pázmándi, K. L.,
Bencze, D.,
Fekete, T.:
Fitokemikáliák immunmoduláló hatásának vizsgálata human monocita eredetű dendritikus sejteken.
Immunol. Szle. 13 (3), 30, 2021.
Bencze, D.,
Fekete, T.,
Pázmándi, K. L.:
Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.
Int. J. Mol. Sci. 22 (8), 1-47, (article identifier: 4190), 2021.
Pázmándi, K. L.,
Sütő, M. I.,
Fekete, T.,
Varga, A.,
Boldizsár, E.,
Boldogh, I.,
Bácsi, A.:
Oxidized base 8-oxoguanine, a product of DNA repair processes, contributes to dendritic cell activation.
Free Radic. Biol. Med. 143, 209-220, 2019.
Fekete, T.,
Bencze, D.,
Pázmándi, K. L.:
Regulatory NLRS control the RLR-mediated type I interferon and inflammatory responses in human dendritic cells.
Immunol. Szle. 10 (3), 13-14, 2018.
Fekete, T.,
Koncz, G.,
Szabó, B.,
Gregus, A.,
Rajnavölgyi, É.:
Interferon gamma boosts the nucleotide oligomerization domain 2-mediated signaling pathway in human dendritic cells in an X-linked inhibitor of apoptosis protein and mammalian target of rapamycin-dependent manner.
Cell. Mol. Immunol. 14 (4), 380-391, 2017.
